TR199903211T2 - Azasteroitler içeren çözeltiler. - Google Patents

Azasteroitler içeren çözeltiler.

Info

Publication number
TR199903211T2
TR199903211T2 TR1999/03211T TR9903211T TR199903211T2 TR 199903211 T2 TR199903211 T2 TR 199903211T2 TR 1999/03211 T TR1999/03211 T TR 1999/03211T TR 9903211 T TR9903211 T TR 9903211T TR 199903211 T2 TR199903211 T2 TR 199903211T2
Authority
TR
Turkey
Prior art keywords
present
azasteroids
solutions containing
invention describes
another aspect
Prior art date
Application number
TR1999/03211T
Other languages
English (en)
Turkish (tr)
Inventor
Frank Parr Alan
Catherine Rizzolio Michele
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR199903211T2 publication Critical patent/TR199903211T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/03211T 1997-08-19 1998-08-17 Azasteroitler içeren çözeltiler. TR199903211T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717444.5A GB9717444D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TR199903211T2 true TR199903211T2 (xx) 2000-04-21

Family

ID=10817633

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03211T TR199903211T2 (xx) 1997-08-19 1998-08-17 Azasteroitler içeren çözeltiler.

Country Status (10)

Country Link
EP (1) EP1005346A2 (de)
JP (1) JP2002511100A (de)
KR (1) KR20010014079A (de)
CN (1) CN1263466A (de)
AU (1) AU8979698A (de)
BR (1) BR9810285A (de)
CA (1) CA2295023A1 (de)
GB (1) GB9717444D0 (de)
TR (1) TR199903211T2 (de)
WO (1) WO1999008684A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
JP2007517788A (ja) * 2004-01-02 2007-07-05 ファルマコン・フォルシュング・ウント・ベラートゥング・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １，２−不飽和アザステロイド類の製造方法
EP2050436A1 (de) 2007-12-21 2009-04-22 Siegfried Generics International AG Pharmazeutische Zubereitungen die Dutasteride enthalten
DE102008059201A1 (de) 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
KR101055412B1 (ko) * 2010-11-19 2011-08-08 (주)비씨월드제약 두타스테라이드를 포함하는 자가유화 에멀젼 조성물 및 이의 제조방법
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
EP3682902A1 (de) * 2012-05-18 2020-07-22 Luoda Pharma Limited Flüssige formulierung
CN103479595B (zh) * 2012-06-13 2015-08-26 成都国弘医药有限公司 一种含有度他雄胺的软胶囊
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
CN103830201A (zh) * 2012-11-20 2014-06-04 重庆医药工业研究院有限责任公司 一种度他雄胺液体软胶囊
EP2949319A1 (de) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmazeutische zusammensetzungen mit einem wirkstoff
JP7017938B2 (ja) * 2018-01-15 2022-02-09 森下仁丹株式会社 ３－オキソ－４－アザアンドロスト－１－エン－１７－カルボン酸誘導体含有製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
WO1997011702A1 (en) * 1995-09-27 1997-04-03 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
WO1998025463A1 (en) * 1996-12-09 1998-06-18 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss

Also Published As

Publication number Publication date
KR20010014079A (ko) 2001-02-26
CA2295023A1 (en) 1999-02-25
AU8979698A (en) 1999-03-08
JP2002511100A (ja) 2002-04-09
CN1263466A (zh) 2000-08-16
BR9810285A (pt) 2000-09-12
WO1999008684A3 (en) 1999-06-10
EP1005346A2 (de) 2000-06-07
WO1999008684A2 (en) 1999-02-25
GB9717444D0 (en) 1997-10-22

Similar Documents

Publication Publication Date Title
DE3484779D1 (de) Pharmazeutische mittel.
TR199903211T2 (xx) Azasteroitler içeren çözeltiler.
TR200000517T2 (tr) Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
NZ280610A (en) Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
FR2760193B1 (fr) Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
EP0684044A3 (de) Ein Dendrimer und Wirkstoff enthaltende Zusammensetzung.
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
TR199902205T2 (xx) Lipofilik bir at�l gaz ihtiva eden t�bb� terkip.
DE69634670D1 (de) Aktives anodenmaterial und nichtwässrige sekundärbatterie
TR200200982T2 (tr) Farmasötik bileşim terkipleri.
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
ID22878A (id) Komposisi aktif secara terapi
TR200100093T2 (tr) Deterjan tableti
DE69631970D1 (de) Archaeoliposome, koenzym q10 enthaltende archaeoliposome und koenzym q10 enthaltende liposome als adjuvans und wirkstoffabgabevehikel
TR199902396T2 (xx) Analjezik birle�ik.
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
TR199901413T2 (xx) Eklem iltihab� i�in yeni tedavi.
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
TR199802573A3 (tr) Bir etken madde içeren çökelmis silisler.
TR199903209T2 (xx) Farmasötik bileşim.
EP0679402A3 (de) Hybridgel, das eine biologisch aktive Substanz sekretiert.
TR200101337T2 (tr) Değiştirilmiş salımlı ensülin sensitizörü için farmasötik terkip ve kullanımı.